Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
1. 请及时下载文件确认是否正确, 系统将在 2026-07-07 17:27:22 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2213-2600(21)00439-2
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260021004392
其他信息:
出版社: Elsevier BV
作者: Mahir Karakas; Ibrahim Akin; Christoph Burdelski; Peter Clemmensen; Hanno Grahn; Dominik Jarczak; Mirjam Keßler; Paulus Kirchhof; Ulf Landmesser; Susanne Lezius; Diana Lindner; Alexandre Mebazaa; Axel Nierhaus; Anil Ocak; Wolfgang Rottbauer; Christoph Sinning; Carsten Skurk; Gerold Söffker; Dirk Westermann; Antonia Zapf; Elvin Zengin; Tanja Zeller; Stefan Kluge
